69 results
8-K
EX-99.1
OCUL
Ocular Therapeutix Inc
11 Mar 24
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
4:10pm
proceeds from existing and new top tier health care investors. Further, I believe that wet AMD is just the beginning for AXPAXLI. We look forward
8-K
EX-1.1
OCUL
Ocular Therapeutix Inc
14 Dec 23
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
8:46am
, officers, directors or agents has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical … elsewhere due to educational activities, health care treatment, military service, temporary internship or employment or otherwise). “Immediate family member
PRE 14A
r3fys 5npffqyd
13 Apr 21
Preliminary proxy
5:07pm
8-K
EX-1.1
fl6vlc 2o4xxhuphtva
18 Dec 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
6:30am
8-K
EX-1.1
mjpv9 czo
16 Oct 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
6:58am